发明授权
- 专利标题: Imidazole based LXR modulators
- 专利标题(中): 咪唑基LXR调节剂
-
申请号: US11993529申请日: 2006-06-26
-
公开(公告)号: US08569352B2公开(公告)日: 2013-10-29
- 发明人: Brett B. Busch , Brenton T. Flatt , Xiao-Hui Gu , Shao-Po Lu , Richard Martin , Raju Mohan , Michael Charles Nyman , Edwin Schweiger , William C. Stevens, Jr. , Tie-Lin Wang , Yinong Xie
- 申请人: Brett B. Busch , Brenton T. Flatt , Xiao-Hui Gu , Shao-Po Lu , Richard Martin , Raju Mohan , Michael Charles Nyman , Edwin Schweiger , William C. Stevens, Jr. , Tie-Lin Wang , Yinong Xie
- 申请人地址: US CA South San Francisco
- 专利权人: Exelixis Patent Company LLC
- 当前专利权人: Exelixis Patent Company LLC
- 当前专利权人地址: US CA South San Francisco
- 代理机构: Fox Rothschild LLP
- 代理商 Gerard P. Norton; Robert N. Henrie, II
- 国际申请: PCT/US2006/024757 WO 20060626
- 国际公布: WO2007/002563 WO 20070104
- 主分类号: A61K31/4174
- IPC分类号: A61K31/4174 ; C07D233/64
摘要:
Compounds of the invention, such as compounds of Formulae IIa, IIb, IIc or IId, and pharmaceutically acceptable salts, isomers, and prodrugs thereof, are useful as modulators of the activity of liver X receptors, where R1, R2, R21, R3 and G are defined herein. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
公开/授权文献
- US20100075964A1 IMIDAZOLE BASED LXR MODULATORS 公开/授权日:2010-03-25
信息查询
IPC分类: